0001752724-21-266304.txt : 20211209 0001752724-21-266304.hdr.sgml : 20211209 20211209122519 ACCESSION NUMBER: 0001752724-21-266304 CONFORMED SUBMISSION TYPE: N-CEN PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20210930 FILED AS OF DATE: 20211209 DATE AS OF CHANGE: 20211209 EFFECTIVENESS DATE: 20211209 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Calvert Management Series CENTRAL INDEX KEY: 0000319676 IRS NUMBER: 526211999 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: N-CEN SEC ACT: 1940 Act SEC FILE NUMBER: 811-03101 FILM NUMBER: 211481323 BUSINESS ADDRESS: STREET 1: 1825 CONNECTICUT AVENUE NW STREET 2: SUITE 400 CITY: WASHINGTON STATE: DC ZIP: 20009 BUSINESS PHONE: 8002256265 MAIL ADDRESS: STREET 1: 1825 CONNECTICUT AVENUE NW STREET 2: SUITE 400 CITY: WASHINGTON STATE: DC ZIP: 20009 FORMER COMPANY: FORMER CONFORMED NAME: CALVERT TAX FREE RESERVES DATE OF NAME CHANGE: 19920703 0000319676 S000059217 Calvert Floating-Rate Advantage Fund C000194063 Calvert Floating-Rate Advantage Fund Class A CFOAX C000194065 Calvert Floating-Rate Advantage Fund Class I CFOIX C000194066 Calvert Floating-Rate Advantage Fund Class R6 CFORX N-CEN 1 primary_doc.xml X0404 N-CEN LIVE 0000319676 XXXXXXXX 811-03101 false false false N-1A S000059217 C000194066 C000194065 C000194063 Calvert Management Series 811-03101 0000319676 549300JLDDCMBLNYVQ38 1825 Connecticut Avenue NW Suite 400 Washington 20009 US-DC US 202-238-2200 State Street Bank and Trust Company 1 Lincoln Street Boston 02111 617-786-3000 Custody and Accounting Records. N N N-1A 3 Y John H. Streur 001251132 Y Cari M. Dominguez N/A N Miles D. Harper, III N/A N Anthony A. Williams N/A N Richard L. Baird, Jr. N/A N John G. Guffey, Jr. 001194366 N Alice Gresham Bullock N/A N Joy V. Jones N/A N Hope L. Brown N/A Two International Place Boston 02110 XXXXXX N N N N N Eaton Vance Distributors, Inc. 8-47939 000037731 5493008E3UZUI6J6EL94 Y N Deloitte & Touche LLP 34 00000000000000000000 Y N N N N N N Calvert Floating-Rate Advantage Fund S000059217 549300GG1YFY0YH1UJ86 N 3 0 0 N/A N N Y N State Street Bank and Trust Company 571474TGEMMWANRLN572 N N N/A N/A N/A Rule 10f-3 (17 CFR 270.10f-3) Rule 12d1-1 (17 CFR 270.12d1-1) Rule 32a-4 (17 CFR 270.32a-4) Rule 22d-1 (17 CFR 270.22d-1) Y Y N N Calvert Research and Management 801-108378 000285127 549300GOOVVJOXZULX66 N DST Asset Manager Solutions, Inc. 84-00896 00000000000000000000 N N N ICE Data Services, Inc. 13-3668779 Tax ID N Refinitiv US Holdings Inc. 549300NF240HXJO7N016 N N State Street Bank and Trust Company 571474TGEMMWANRLN572 N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) N DST Asset Manager Solutions, Inc. 84-00896 SEC File Number N N N Calvert Research and Management 549300GOOVVJOXZULX66 Y N N E*TRADE Securities LLC 8-44112 000029106 549300PJRJFMBCDPWR57 0.00000000 PT Morgan Stanley Sekuritas Indonesia N/A N/A 549300JVGZMY503T1I56 ID 0.00000000 Morgan Stanley Corretora de Titulos e Valores Mobiliarios S.A. N/A N/A HN65QO5XTFJICDM5V937 BR 0.00000000 Morgan Stanley Hong Kong Securities Limited N/A N/A 549300SY0QG9QQ09KW20 HK 0.00000000 Memx Holdings LLC N/A N/A 00000000000000000000 0.00000000 Morgan Stanley Asia (Singapore) Pte. N/A N/A S7TFLKD0ZWWBHLSCAD37 SG 0.00000000 RMB Morgan Stanley Pty Ltd N/A N/A 54930026T33G80GFU737 ZA 0.00000000 Morgan Stanley Europe SE N/A N/A 54930056FHWP7GIWYY08 DE 0.00000000 Morgan Stanley France N/A N/A PK168Q24DU7QQ2T4QF97 FR 0.00000000 Morgan Stanley Australia Securities Limited N/A N/A 6NYZXKE9GUP7XNI56S88 AU 0.00000000 Limited Liability Company 'Morgan Stanley Bank' N/A N/A KXR3XGBYJIDK7XYBRF48 RU 0.00000000 Morgan Stanley Wealth Management Canada Inc N/A N/A 549300VVMTKCWZUZVJ61 CA 0.00000000 EOS Precious Metals Limited N/A N/A 00000000000000000000 GB 0.00000000 Prime Dealer Services Corp. 8-47025 000036142 549300U1ZGT51W4F9866 0.00000000 Morgan Stanley Distribution, Inc. 8-44766 000030344 54930020DF0S7EF78K71 0.00000000 Morgan Stanley Senior Funding, Inc. N/A N/A XRR2REEVVJS58CENNG14 0.00000000 Morgan Stanley Saudi Arabia Company N/A N/A 549300JYPS6Z0I1BVB86 SA 0.00000000 Morgan Stanley Mexico, Casa de Bolsa, S.A. de C.V. N/A N/A FHYNAGT8UJJJOGL0BI58 MX 0.00000000 Morgan Stanley Canada Limited N/A N/A 54930065FO7CXEUTGL76 CA 0.00000000 Morgan Stanley Taiwan Limited N/A N/A 549300UX7BN34UFIPA91 TW 0.00000000 Fxglobalclear Limited N/A N/A 00000000000000000000 GB 0.00000000 Creditderiv Limited N/A N/A 00000000000000000000 GB 0.00000000 Morgan Stanley MUFG Securities Co., Ltd. N/A N/A 549300OB5SQ53A8BTO30 JP 0.00000000 Turquoise Global Holdings Limited N/A N/A 2138006SKBMJJUE2HV03 GB 0.00000000 Morgan Stanley Asia (Singapore) Securities Pte Ltd N/A N/A 549300JN2HN4WBKARP61 SG 0.00000000 Eaton Vance Management (International) Limited N/A 000281469 549300HBYTOFMPCTSB79 GB 0.00000000 Morgan Stanley Capital Services LLC N/A N/A I7331LVCZKQKX5T7XV54 0.00000000 Morgan Stanley Capital Group Inc. N/A N/A VB7RXNZGO6KVDABYB880 0.00000000 Morgan Stanley Gateway Securities JSC N/A N/A 5493007LT7NGWGYW4E84 VN 0.00000000 MorganStanley Menkul Degerler Anonim Sirketi N/A N/A 549300VJZV93UIORC566 TR 0.00000000 Morgan Stanley Capital Products LLC N/A N/A IVNH9ABHJY5L0X3RKW69 0.00000000 Morgan Stanley & Co. International PLC N/A N/A 4PQUHN3JPFGFNF3BB653 GB 0.00000000 Morgan Stanley & Co. LLC 8-15869 000008209 9R7GPTSO7KV3UQJZQ078 0.00000000 Equilend LLC 8-53738 000119107 213800BN4DRR1ADYGP92 0.00000000 Morgan Stanley, S.V., S.A. N/A N/A 549300GSKN0B8BOS5L68 ES 0.00000000 OTCDeriv Limited N/A N/A 213800AJVXMIB2FPEM07 GB 0.00000000 Eaton Vance Distributors, Inc. 8-47939 000037731 5493008E3UZUI6J6EL94 0.00000000 Morgan Stanley Smith Barney LLC 8-68191 000149777 7PDDXEMZ0ZV0CEDU4D16 0.00000000 Morgan Stanley Bank, National Association N/A N/A G1MLHIS0N32I3QPILB75 0.00000000 Morgan Stanley Asia Limited N/A N/A 549300KZJFHUSUNKZZ03 HK 0.00000000 Morgan Stanley Wealth Management Australia Pty Ltd N/A N/A 549300VR74G9RZHCCE31 AU 0.00000000 Morgan Stanley India Company Private Limited N/A N/A OYO6KC46QF54MHNL5D43 IN 0.00000000 0.00000000 Deutsche Bank Securities Inc. 8-17822 000002525 9J6MBOOO7BECTDTUZW19 5204955.91000000 UBS Securities LLC 8-22651 000007654 T6FIZBDPKLYJKFCRVK44 4177302.56000000 RBC Capital Markets, LLC 8-45411 000031194 549300LCO2FLSSVFFR64 4320504.19000000 Barclays Capital Inc. 8-41342 000019714 AC28XWWI3WIBK2824319 11734038.48000000 Goldman Sachs & Co. LLC 8-129 000000361 FOR8UP27PHTHYVLBNG30 11945985.74000000 Credit Suisse Securities (USA) LLC 8-422 000000816 1V8Y6QCX6YMJ2OELII46 8759141.99000000 Jefferies LLC 8-15074 000002347 58PU97L1C0WSRCWADL48 5578512.76000000 J.P. Morgan Securities LLC 8-35008 000000079 ZBUT11V806EZRVTWT807 20173820.70000000 Citigroup Global Markets Inc. 8-8177 000007059 MBNUM2BPBDO7JBLYG310 19101956.75000000 BofA Securities, Inc. 8-69787 000283942 549300HN4UKV1E2R3U73 12868664.90000000 112490460.72000000 N 97361502.26692307 Committed 45000000.00000000 N N N true INTERNAL CONTROL RPT 2 NCEN_811-03101_52625686_0921.htm calvertmgtsflrate2.htm - Generated by SEC Publisher for SEC Filing

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the shareholders and the Board of Trustees of Calvert Management Series:

In planning and performing our audit of the financial statements of Calvert Management Series, including Calvert Floating-Rate Advantage Fund (the "Fund"), as of and for the year ended September 30, 2021, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), we considered the Fund’s internal control over financial reporting, including controls over safeguarding securities, as a basis for designing our auditing procedures for the purpose of expressing our opinion on the financial statements and to comply with the requirements of Form N-CEN, but not for the purpose of expressing an opinion on the effectiveness of the Fund’s internal control over financial reporting. Accordingly, we express no such opinion.

The management of the Fund is responsible for establishing and maintaining effective internal control over financial reporting. In fulfilling this responsibility, estimates and judgments by management are required to assess the expected benefits and related costs of controls. A fund’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A fund’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the fund; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the fund are being made only in accordance with authorizations of management and directors of the fund; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of a fund's assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

A deficiency in internal control over financial reporting exists when the design or operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the fund’s annual or interim financial statements will not be prevented or detected on a timely basis.

Our consideration of the Fund’s internal control over financial reporting was for the limited purpose described in the first paragraph and would not necessarily disclose all deficiencies in internal control that might be material weaknesses under standards established by the PCAOB. However, we noted no deficiencies in the Fund’s internal control over financial reporting and its operation, including controls for safeguarding securities, that we consider to be a material weakness, as defined above, as of September 30, 2021.


 

This report is intended solely for the information and use of management and the Board of Trustees of the Fund and the Securities and Exchange Commission and is not intended to be and should not be used by anyone other than these specified parties.

/s/ Deloitte & Touche LLP

Boston, Massachusetts

November 22, 2021